Represented of Check-Cap Ltd. in a $35 million registered direct offering of ordinary shares and warrants. H.C. Wainwright & Co., LLC served as exclusive placement agent for the offering. Check-Cap, listed on NASDAQ, is a clinical stage medical diagnostics company aiming to redefine colorectal cancer (CRC) screening through the introduction of C-Scan®, the first and only patient-friendly preparation-free screening […]